Current with legislation from the 2023 Regular and Special Sessions signed by the Governor as of November 21, 2023.
Section 531.0737 - [Repealed Effective 4/1/2025] Drug Utilization Review Board: Conflicts of Interest(a) A voting member of the Drug Utilization Review Board may not have a contractual relationship, ownership interest, or other conflict of interest with a pharmaceutical manufacturer or labeler or with an entity engaged by the commission to assist in the development of the preferred drug lists or in the administration of the Medicaid Drug Utilization Review Program.(b) The executive commissioner may implement this section by adopting rules that identify prohibited relationships and conflicts or requiring the board to develop a conflict-of-interest policy that applies to the board.Tex. Gov't. Code § 531.0737
Repealed by Acts 2023, Texas Acts of the 88th Leg.- Regular Session, ch. 769,Sec. 3.01, eff. 4/1/2025.Renumbered from Tex. Gov't. Code § 531.0692 and amended by Acts 2015, Texas Acts of the 84th Leg. - Regular Session, ch. 837,Sec. 3.08, eff. 1/1/2016.Renumbered from Tex. Gov't. Code § 531.0692 and amended by Acts 2015, Texas Acts of the 84th Leg. - Regular Session, ch. 946,Sec. 2.08, eff. 1/1/2016.Added by Acts 2009, 81st Leg., R.S., Ch. 1286, Sec. 1, eff. 9/1/2009.